Maze Therapeutics Doses First Patient in Phase 2 HORIZON Clinical Trial Evaluating MZE829 as a Potential Treatment for APOL1 Kidney Disease
We are excited to announce the initiation of our HORIZON Study for MZE829, a Phase 2 clinical trial with a novel, potential new medicine that could disrupt current treatment for AKD,” said Harold ...
Trump Media Is Moving Into the Financial Services Industry
The parent company of Truth Social said it had applied for trademarks for investment products that would allow supporters to ...
The Express Tribune on MSN1d
WATCH: PCB unveils logo for milestone HBL PSL 10 season
The Pakistan Cricket Board (PCB) unveiled the highly anticipated logo for the 10th edition of the HBL Pakistan Super League (PSL), ahead of the tournament's start from 8 April to 19 May 2025.This ...
IRCODE INTRODUCES LIVE+: A NEW STANDARD FOR REAL-TIME INTERACTION AND LIVE COMMERCE
IRCODE, a game-changing technology redefining the boundaries of live sports and interactive media, has announced the launch of LIVE+, a new capability designed ...
Is help from prospect Isaac Howard on the horizon for the Lightning?
In his third season and second at Michigan State, the 2020 1st-round pick has emerged as one of the best players in college ...